Fact-Checking Serena Williams and Ozempic: What Medication Did She Really Use?
For more than two decades, Serena Williams possessed one of the most rigorously analyzed physiques in global sport. Her body was built for explosive kinetic output: crushing serves exceeding 120 mph, blistering baseline sprints, and grueling three-set battles in punishing humidity. After retiring from competitive tennis following the 2022 US Open and welcoming her second daughter, Adira River Ohanian, in August 2023, Williams encountered a physiological barrier that defied her standard conditioning regimens.
Williams spoke candidly across digital video diaries about her inability to shed approximately 34 pounds of postpartum weight. Even while maintaining an intense post-retirement fitness routine that would break most recreational runners, the scale refused to budge. "My body just holds on to weight after babies," Williams shared with her followers, describing the hormonal and metabolic shifts that frequently accompany postpartum recovery. For elite athletes accustomed to an input-equals-output metabolic equation, this hormonal resistance often presents a profound psychological shock.
When Williams reappeared months later displaying a noticeably leaner frame, social platforms like TikTok and X erupted. Commentators immediately classified her transformation under the catch-all moniker "Ozempic face," assuming quick chemical intervention. In doing so, public discourse compressed complex postpartum endocrinology into a trending online search phrase.
